MedPath

Effectiveness of Repeated Amiodarone Dosing Regimen Versus Standard Dosing Regimen in Atrial Fibrillation Patient With Rapid Ventricular Response

Phase 4
Not yet recruiting
Conditions
Atrial Fibrillation
Interventions
Registration Number
NCT06262932
Lead Sponsor
Police General Hospital, Thailand
Brief Summary

The goal of this clinical trial is to compare in atrial fibrillation patient with rapid ventricular response. The main question it aims to answer are Effectiveness of Repeated Amiodarone dosing regimen versus standard dosing regimen in Atrial fibrillation patient with rapid ventricular response Participants will receive Amiodarone iv treatment with different regimen

* Repeated dosing regimen

* Standard dosing regimen

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
32
Inclusion Criteria
  • Age above 18 years old
  • Atrial fibrillation with rapid ventricular response patient (ventricular rate > 110)
Read More
Exclusion Criteria
  • Baseline EKG Corrected QT interval (QTc) < 500 msec
  • History of pulmonary fibrosis
  • History of Cirrhosis
  • Cardiac Index <2.2 L/min/m2 or Cardiogenic shock
  • Unstable arrhythmia
  • Receive amiodarone within 3 months prior to present illness
  • Pregnancy
  • Amiodarone or Iodine allergy
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Repeated amiodarone bolus dosing regimenAmiodaroneAn Initial 150 mg IV amiodarone bolus should be given over a 15-minute period. If the heart rate is still over 110 minutes after the initial treatment, provide an additional 150 mg IV amiodarone bolus over a 15-minute period. During the first 24 hours, this bolus may be administered up to three times in total. Within 24 hours of finishing the first bolus dosage, 900 mg of amiodarone will be administered intravenously.
Standard dosing regimenAmiodaroneAn Initial 150 mg IV amiodarone bolus should be given over a 15-minute period, then a 24-hour amiodarone loading infusion 900 mg over 24 hours
Primary Outcome Measures
NameTimeMethod
Heart rate6-hours after receiving amiodarone bolus

Percentage of patients who have Atrial fibrillation with rapid ventricular response, the percentage of patients who have heart rate below 110 bpms at 6 hours after receiving a repeated amiodarone bolus and loading dose regimen to the percentage of patients who have heart rate below 110 bpms at 6 hour after a conventional amiodarone IV loading dose regimen

Secondary Outcome Measures
NameTimeMethod
Heart rate24-hours after receiving amiodarone bolus

Percentage of patients who have Atrial fibrillation with rapid ventricular response, the percentage of patients who have heart rate below 110 bpms at 24 hours after receiving a repeated amiodarone bolus and loading dose regimen to the percentage of patients who have heart rate below 110 bpms at 6 hour after a conventional amiodarone IV loading dose regimen

Major adverse cardiovascular events30 days after receiving amiodarone bolus

Number of MACE \[MACE defined as acute myocardial infarction (AMI), stroke, or cardiovascular death\]

Phlebitis24-hours after receiving amiodarone bolus

Rate of phlebitis complication during amiodarone infusion

Normal sinus rhythm at 24 hours24-hours after receiving amiodarone bolus

Percentage of patients who develop Atrial fibrillation with rapid ventricular response, the percentage of patients who have converted to sinus rhythm at 24-hours after receiving a repeated amiodarone bolus and loading dose regimen to the percentage of patients who have converted to sinus rhythm after a conventional amiodarone IV loading dose regimen

Changed in heart rate24-hours after receiving amiodarone bolus

Compare number of total heart rate induction in patients who received a repeated amiodarone bolus and loading dose regimen and a conventional amiodarone IV loading dose regimen at 24 hrs

© Copyright 2025. All Rights Reserved by MedPath